Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edison T Liu

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Breast Cancer Research and Treatment|May 21, 2003
HER-2/neu and topoisomerase IIalpha in breast cancerTero A H Järvinen, Edison T Liu
BMC Biology|June 10, 2010
Q&A: ChIP-seq technologies and the study of gene regulationEdison T Liu, Sebastian Pott, Mikael Huss
Current Cancer Drug Targets|November 15, 2006
Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancerTero A H Järvinen, Edison T Liu
Nature Genetics|October 31, 2007
A gene harvest revealing the archeology and complexity of human diseaseEnrico Petretto, Edison T Liu, Timothy J Aitman
Nature Genetics|May 2, 2003
Genetic background is an important determinant of metastatic potentialKent Hunter, Danny R Welch, Edison T Liu
Biochemical and Biophysical Research Communications|August 25, 2004
Susceptibility to cell death induced by blockade of MAPK pathway in human colorectal cancer cells carrying Ras mutations is dependent on p53 statusZhen Wang, Yuqing Li, Edison T Liu, et al.
JCO Precision Oncology|March 9, 2026
Prevalence of <i>BRCA1</i> Promoter Methylation in Cohorts of Individuals With and Without Cancer Assessed by Circulating Cell-Free DNAEdison T Liu, Margaret Antonio, Tracy Nance, et al.
JAMA Oncology|April 8, 2016
Patient-Derived Tumor Xenografts: Why Now?Edison T Liu, Carol J Bult, Leonard D Shultz
Cancer Cell|April 18, 2006
In the pursuit of complexity: systems medicine in cancer biologyEdison T Liu, Vladimir A Kuznetsov, Lance D Miller
The Journal of Biological Chemistry|February 1, 2002
Identification of Myc-mediated death response pathways by microarray analysisQiang Yu, Mei He, Norman H Lee, et al.
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Breast Cancer Research and Treatment|May 21, 2003
HER-2/neu and topoisomerase IIalpha in breast cancerTero A H Järvinen, Edison T Liu
BMC Biology|June 10, 2010
Q&A: ChIP-seq technologies and the study of gene regulationEdison T Liu, Sebastian Pott, Mikael Huss
Current Cancer Drug Targets|November 15, 2006
Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancerTero A H Järvinen, Edison T Liu
Nature Genetics|October 31, 2007
A gene harvest revealing the archeology and complexity of human diseaseEnrico Petretto, Edison T Liu, Timothy J Aitman
Nature Genetics|May 2, 2003
Genetic background is an important determinant of metastatic potentialKent Hunter, Danny R Welch, Edison T Liu
Biochemical and Biophysical Research Communications|August 25, 2004
Susceptibility to cell death induced by blockade of MAPK pathway in human colorectal cancer cells carrying Ras mutations is dependent on p53 statusZhen Wang, Yuqing Li, Edison T Liu, et al.
JCO Precision Oncology|March 9, 2026
Prevalence of <i>BRCA1</i> Promoter Methylation in Cohorts of Individuals With and Without Cancer Assessed by Circulating Cell-Free DNAEdison T Liu, Margaret Antonio, Tracy Nance, et al.
JAMA Oncology|April 8, 2016
Patient-Derived Tumor Xenografts: Why Now?Edison T Liu, Carol J Bult, Leonard D Shultz
Cancer Cell|April 18, 2006
In the pursuit of complexity: systems medicine in cancer biologyEdison T Liu, Vladimir A Kuznetsov, Lance D Miller
The Journal of Biological Chemistry|February 1, 2002
Identification of Myc-mediated death response pathways by microarray analysisQiang Yu, Mei He, Norman H Lee, et al.
Pageof 20